Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
16.56
-0.05 (-0.30%)
At close: Feb 13, 2026, 4:00 PM EST
16.58
+0.02 (0.12%)
After-hours: Feb 13, 2026, 4:10 PM EST
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $505.13 million as of February 13, 2026. Its market cap has increased by 6.49% in one year.
Market Cap
505.13M
Enterprise Value
-170.92M
1-Year Change
6.49%
Ranking
Category
Stock Price
$16.56
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $385.32M to $505.13M, an increase of 31.09%. That is a compound annual growth rate of 4.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 505.13M | -18.57% |
| Dec 31, 2025 | 620.29M | -3.27% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vor Biopharma | 530.62M |
| Gossamer Bio | 530.03M |
| Ginkgo Bioworks Holdings | 528.01M |
| Contineum Therapeutics | 527.49M |
| Alto Neuroscience | 524.71M |
| Tenax Therapeutics | 513.21M |
| ADC Therapeutics | 494.27M |
| Prothena Corporation | 482.32M |